6 completed, 1 terminated. 7 Phase 3.
By phase and status
Follow AVE 5026: new trials by email Literature Review of AVE 5026 trials Research Report on AVE 5026
Trials (filtered) newest first · largest first
All 7 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery Enoxaparin sodium, Semuloparin sodium, Placebo - Venous Thromboembolism | Phase 3 | Completed | 1003 | 2008-07-01 | 2013-01-23 |
Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted Mobility Semuloparin sodium, Enoxaparin sodium - Venous Thromboembolism | Phase 3 | Terminated | 421 | 2008-07-01 | 2013-01-23 |
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery Semuloparin sodium, Enoxaparin, Placebo - Venous Thromboembolism | Phase 3 | Completed | 1150 | 2008-07-01 | 2013-01-23 |
Evaluation of AVE5026 as Compared to Placebo for the Extended Prophylaxis of Venous Thromboembolism in Patients Having Undergone Hip Fracture Surgery Open-label Semuloparin sodium, Placebo (for Semuloparin sodium), Semuloparin sodium - Venous Thromboembolism | Phase 3 | Completed | 469 | 2008-06-01 | 2013-06-14 |
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery Semuloparin sodium, Enoxaparin sodium, Placebo - Venous Thromboembolism | Phase 3 | Completed | 2326 | 2008-06-01 | 2013-01-23 |
Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy Semuloparin sodium, Placebo (for semuloparin) - Venous Thromboembolism, Cancer | Phase 3 | Completed | 3212 | 2008-06-01 | 2013-01-23 |
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery Semuloparin Sodium, Enoxaparin sodium, Placebo - Venous Thromboembolism | Phase 3 | Completed | 4413 | 2008-04-01 | 2013-12-16 |
Conditions studied
Venous Thromboembolism (7) · Hip Fractures (1) · Neoplasms (1) · Venous Thrombosis (1)
Sponsors
Sanofi (7)
Countries
Canada (7) · Mexico (7) · Russia (7) · Ukraine (7) · United States (7) · Belarus (6) · Czechia (6) · India (6) · Romania (6) · South Africa (6) · Argentina (5) · Australia (5) · Chile (5) · Colombia (5) · Denmark (5)
Top investigators
Alexander Turpie, MD (3) · William D. Fisher, MD (2) · Ajay Kakkar, Prof., MD, PhD (1) · Alexander G. Turpie (1) · Alexander G. Turpie, MD (1) · Giancarlo Agnelli, MD (1) · Patrick Mismetti, MD (1)
Results publications
PMID 22429800, PMID 22335737, PMID 23539696, PMID 24374549, PMID 33337539
NIH funding
2008 (1)